Clinical Outcomes

Summarized here are hospital research results of Nozin programs. Each facility studied their Nozin programs which decolonize patients with Nozin® Nasal Sanitizer® antiseptic to help reduce the infection risk from MRSA/MSSA nasal colonization.

Evidence

Evidence shows that nasal bacteria are a primary component in the spread of infection.

%

30% of population carry Staph aureus in the nose⁸

%

80% of wound infections traced by DNA to bacteria in the patients' own nose⁹

%

44% reduction in ICU infections with universal nasal and skin decolonization³

%

81% infection reduction with Nozin programs added to an existing IP bundle²

Nasal Decolonization White Papers

Healthcare professionals are invited to download our FREE white papers on the nasal decolonization landscape.

Emerging Strategies on Achieving Nasal DecolonizationNasal Decolonization's Broadening Application

 

Emerging Strategies on Achieving Nasal Decolonization For Reducing Hospital Acquired Infections
& Nasal Decolonization's Broadening Application: Replacing Contact Precautions

News and Major Published Articles

Clinical Outcomes Matter

Summarized here are hospital research results of Nozin programs. Each facility studied their Nozin programs which decolonize patients with Nozin® Nasal Sanitizer® antiseptic to help reduce the infection risk from MRSA/MSSA nasal colonization.

Baylor SSI Study Published²

Perioperative participation of orthopedic patients and surgical staff in a nasal decolonization intervention to reduce Staphylococcus...

Wellstar Cobb Hospital

A safer, less costly SSI prevention protocol—Universal versus targeted preoperative decolonization

Replacing Contact Precautions for MRSA patients

Can a nasal and skin decolonization protocol safely replace contact precautions for colonized MRSA patients?

Nasal Decolonization and HAI Prevention

New article by Sue Barnes, RN, CIC, the former national program leader for infection prevention at Kaiser Permanente. Click below to view full article.

Impacts of Alcohol-based Nasal Decolonization on Infection Rates

Impacts of Coordinated, Hospital-wide Use of Alcohol-based Nasal Decolonization on Infection Rates, Patient Care and Cost Savings.

IDSA Annual Meeting Presentation and AJIC Article

Baylor Orthopedic and Spine Hospital at Arlington presented results of nasal decolonization study at IDSA and then published in AJIC.

APIC 2016 Conference

Nina Deatherage, BSN, RN, PHN, CIC, and Infection Control Lead at Marshall Medical Center presented results of eliminating MRSA contact precautions at Marshall.

Strength in Numbers

In this article the author, Valerie Dimond, makes a case for stronger cooperation in achieving goals of Antimicrobial Stewardship Programs (ASPs).

Reduction of nasal Staphylococcus aureus carriage¹

The American Journal of Infection Control (AJIC) has in press the article: “Reduction of nasal Staphylococcus aureus carriage in health care professionals by treatment with...

Marshall Medical Center Study reducing infection risk with Nozin gets Press

Reuters is among a number of news outlets that have run the Business Wire press article: “Nozin Nasal Drug Reduces Risk and Cost Associated with MRSA at Marshall...

References

1. Steed LL et al. Am J Infect Control 2014; 42:841-846.
2. Mullen A et al. Am J Infect Control 2017; 45(5):554-556.
3. Huang SS et al. N Engl J Med 2013; 368(24):2255-2265. (nasal decolonization with antibiotic)
4. Deatherage N. Am J Infect Control 2016; 44(6) Supplement, S101-S102.
5. Huang SS et al. Infect Control Hosp Epidem 2014; 35(S3):S23-S31.
6. Kalmeijer MD et al. Infect Control Hosp Epidem 2000; 21:319-323.
7. Thakkar V et al. Clin Neurol Neurosurg 2014; 125:94-97.
8. Werthheim HFL et al. Lancet 2005; 5:751-762.
9. Coates T et al. J Antimicrob Chemother 2009; 64:9-15.
10. Tammelin A et al. Infect Control Hosp Epidemiol 2003; 24(9):686-689.


Health Professionals:
Request a comprehensive analysis of your colonization risk mitigation protocols today.

© 2004-2023 Global Life Technologies Corp. All rights reserved. All trademarks are property of their respective owners. Nozin® Nasal Sanitizer® antiseptic is an OTC topical antiseptic drug and no claim is made that it has an effect on any specific disease. | Patent Nos.